SAN FRANCISCO, Sept. 04, 2019 (GLOBE NEWSWIRE) — iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, announced today that it has commenced an underwritten public offering of $100,000,000 of shares of its common stock. All of the shares in […]
Financial
BioTelemetry, Inc. Named to Fortune Magazine’s 100 Fastest-Growing Companies List
MALVERN, Pa., Sept. 03, 2019 (GLOBE NEWSWIRE) — BioTelemetry, Inc. (NASDAQ:BEAT), the leading remote medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, announced today it has been ranked 31st on Fortune Magazine’s 100 Fastest-Growing Companies list for 2019. The […]
Stereotaxis Announces Uplisting to NYSE American
ST. LOUIS, Sept. 03, 2019 (GLOBE NEWSWIRE) — Stereotaxis (OTCQX: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced that its common stock has been approved for listing on the NYSE American. The Company’s common stock will begin trading on the NYSE American exchange under […]
CHF Solutions, Inc. Appoints World-Renowned Heart Failure Cardiologist, Maria Rosa Costanzo, M.D. to Company’s Board of Directors
EDEN PRAIRIE, Minn., Sept. 04, 2019 (GLOBE NEWSWIRE) — CHF Solutions, Inc. (Nasdaq:CHFS) today announced that Maria Rosa Costanzo, M.D. has been appointed to the Company’s Board of Directors. Dr. Costanzo is the medical director, Heart Failure Research, at Advocate Heart Institute, and the medical director for Advanced Heart Failure […]
Vensana Capital Launches with Inaugural $225 Million Fund
New independent firm founded by leading medical technology venture capital investors Justin Klein & Kirk Nielsen with the support of Versant Ventures Vensana seeks to back the next generation of breakthrough innovations in medical devices, diagnostics and data science, and other medical technology sub-sectors MINNEAPOLIS & WASHINGTON–(BUSINESS WIRE)–Vensana Capital today […]
Mesoblast Reports 2019 Full Year Results
NEW YORK and MELBOURNE, Australia, Aug. 29, 2019 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq: MESO; ASX: MSB) today reported strong operational progress and financial highlights for the fourth quarter and full-year ended June 30, 2019 (FY2019). Mesoblast Chief Executive Dr Silviu Itescu stated: “The Company is well positioned to deliver […]
Endonovo Therapeutics Appoints Dr. Geoffrey Abrams of Stanford University to Its Scientific Advisory Board
LOS ANGELES, Aug. 30, 2019 (GLOBE NEWSWIRE) — via NetworkWire — Endonovo Therapeutics Inc. (OTCQB: ENDV) (“Endonovo” or the “Company”), a commercial-stage developer of noninvasive Electroceutical® therapeutic devices, today announces the appointment of orthopedic surgeon Dr. Geoffrey Abrams to its scientific advisory board. “We are thrilled to announce that Dr. Abrams […]
Medtronic EVP & CVG President Mike Coyle to Speak at Wells Fargo Securities Healthcare Conference
DUBLIN, Aug. 29, 2019 (GLOBE NEWSWIRE) — Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced that it will participate in the 14th Annual Wells Fargo Securities Healthcare Conference on Thursday, September 5, 2019, in Boston. Mike Coyle, executive vice president and president of the Cardiac and Vascular Group (CVG) […]
Cardiology Compensation Continues to Rise; First Heart Failure Compensation Data Reported
MedAxiom New Survey of 2,300 physicians reveals impactful health care industry trends NEPTUNE BEACH, Fla.–(BUSINESS WIRE)–MedAxiom, an American College of Cardiology Company, the nation’s leading cardiovascular health care performance community and top cardiovascular-specific consulting firm, has released its seventh annual. The report reveals trends that help cardiovascular organizations navigate an […]
Orchestra BioMed™ Appoints Dennis Donohoe, M.D., Leading Clinical Development Expert, as Chief Medical Officer
Dr. Donohoe brings nearly 30 years of successful clinical and regulatory experience advancing medical devices in the cardiology and endovascular space NEW HOPE, Pa., Aug. 27, 2019 (GLOBE NEWSWIRE) — Orchestra BioMed, Inc. (“Orchestra BioMed” or the “Company”), a biomedical innovation company providing high-impact solutions for large unmet needs in […]
Recent
Accelerating Adoption of AI Reporting in Radiology Has Propelled Replacement of Legacy SR Integration Technology
FDA Grants Coredio Breakthrough Designation for AI Platform Bringing Advanced Heart Failure Assessment Beyond the Hospital
BioCardia Announces Japan PMDA Record Of Advice Supports Regulatory Submission For Approval Of CardiAMP Cell Therapy For Ischemic Heart Failure
Popular
- No commented posts yet